Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Court Appoints Two Camp Lejeune Justice Act Settlement Masters To Facilitate Resolution of Claims As the filing deadline for Camp Lejeune lawsuits approach, parties are looking at both settlement options and a series of bellwether trials to resolve the litigation. July 12, 2024 Irvin Jackson Add Your Comments A group of four federal judges who are overseeing all lawsuits and administrative claims over Camp Lejeune water contamination, have determined that two settlement masters are probably necessary to help speed up the slow claim resolution process, which has bogged down the litigation. In August 2022, the Camp Lejeune Justice Act (CLJA) was signed into law, providing a two-year filing window for individuals who lived, served or worked on the North Carolina military base from the mid-1950s to late 1980s to seek financial compensation for various types of cancer and other ailments linked to toxic chemicals that contaminated the water supply. That filing window closes in just a few weeks, on August 10, and the U.S. Government has already received notice that nearly 300,000 individuals intend to file lawsuits, which all must be brought in the U.S. District Court for the Eastern District of North Carolina. Despite the introduction of an elective settlement option for Camp Lejeune lawsuits announced in September 2023, only a small number of claims have actually been successfully resolved. Although many critics have argued the amount of compensation available through that elective option is insufficient, a recent report suggests that the Navy itself has confirmed only 136 Camp Lejeune water contamination claims may be eligible for a settlement offer, and only 105 individuals have actually had an offer to settle their claims extended. This represents only 0.004% of Camp Lejeune claims presented so far. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More With resolutions lagging and the deadlines approaching, U.S. District Judges Richard E. Myers II, Terrence W. Boyle, Louise W. Flanagan and James C. Dever III issued a case management order (PDF) on July 9, assigning two settlement masters to work with the parties to resolve the litigation, Thomas J. Perrelli and Christopher G. Oprison. “The Court has determined after careful consideration that at this time settlement of this litigation would best be served by appointment of both Mr. Perrelli and Mr. Oprison as Settlement Masters,” the Judges wrote. “They have advised the Court that they agree to serve jointly.” Settling Camp Lejeune lawsuits is critical to avoid the need for hundreds of thousands of individual claims to go forward with bench trials, creating a significant financial and time burden on the Courts ad all parties involved. The special masters have been charged with helping to facilitate global settlement discussions, but do not have the power to adjudicate any issues impacting the litigation, the judges noted. Camp Lejeune Track 1 Bellwether Trials Order While the parties are working to determine if a global Camp Lejeune settlement program can be established, the Court is moving forward with a bellwether process, preparing several “tracks” of claims involving different categories of injuries for early trial dates, which are designed to help gauge how the Court may respond to certain evidence and testimony that is likely to be repeated throughout the litigation. In October 2023, the Court established a Camp Lejeune Lawsuit Track 1 criteria, and the parties selected a group of 100 cases to go through early discovery involving the following five categories of injuries: Bladder cancer Kidney cancer Leukemia Parkinson’s disease Non-Hodgkin’s lymphoma To help focus efforts, the Court recently directed the parties to narrow down the original list of 100 cases to a group of 25 claims that will be eligible for trial, including five cases from each of the five injury categories, with plaintiffs selecting three of the claims and the U.S. government selecting the other two. On the same day the Camp Lejeune settlement masters were appointmented, the judges also issued a trial order (PDF), announcing the 25 cases selected for the Track 1 bellwether trial pool and setting an August 11, 2024, deadline for general discovery on these cases to be completed. While the outcome of these early bellwether trials will not have a binding impact on other claims in the litigation, they will be closely watched by lawyers involved in the cases, as the average amounts of any Camp Lejeune lawsuit payouts awarded may help the parties in global settlement negotiations for various types of injuries. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Camp Lejeune, Camp Lejeune Settlement, Department of The Navy, Lawsuits, North Carolina, Veteran Affairs, Veterans, Water Contamination More Camp Lejeune Lawsuit Stories Information About 2,500 Camp Lejeune Injury Claims May Influence Settlement Process October 27, 2025 Trichloroethylene Exposure Linked to Parkinson’s Disease Risk: Study October 8, 2025 Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025) Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)